Everyone’s on GLP-1s. But at What Cost?
The article discusses the normalization of GLP-1 drugs like Tirzepatide in popular culture, particularly through reality television. It highlights the struggles of influencer Layla Taylor, who opened up about her mental health issues related to her use of the drug. The piece raises concerns about the accessibility and marketing of these medications, often without proper oversight or consideration of their potential consequences.
- ▪Layla Taylor, a 25-year-old influencer, shared her struggles with using the GLP-1 drug Tirzepatide on reality television.
- ▪Despite her admission of mental health issues, the show largely downplayed her story while promoting advertisements for telehealth companies offering weight loss solutions.
- ▪The article points out that telehealth providers like Ro are not regulated by the FDA, raising concerns about the ease of obtaining prescriptions without proper evaluations.
Opening excerpt (first ~120 words) tap to expand
freestar.config.enabled_slots.push({ placementName: "motherjones_right_rail_1", slotId: "ROS_ATF_300x600" }); Mother Jones illustration; Zuma (5) Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. When Layla Taylor, the 25-year-old Utah influencer and member of MomTok, went public with her use of the GLP-1 drug Tirzepatide in the latest season of The Secret Lives of Mormon Wives, her pain was palpable. “I’m so exhausted all the time because I don’t eat,” Taylor shares with two cast-mates during a spa day. “My body hurts every night when I go to bed.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Mother Jones.
Discussion
0 commentsMore from Mother Jones
